ExThera Medical Corporation is a privately held Delaware C corporation.
The company's focus is on the introduction of innovative device-based clinical treatments for both drug-resistant and drug-susceptible bloodstream infections.
Please contact the following to learn more about our current investment programs:
GREG DOLLARHYDE | DIRECTOR
MICHAEL BENJAMIN | CONTROLLER
ExThera Medical Corporation